Auxilium Biotechnologies today announced enrollment of the first patient in a pivotal trial for its NeuroSpan Bridge implant for nerve regeneration.
Medtronic (NYSE: MDT)+
announced today that it received CE mark for several expanded indications for its Prevail balloon catheter
AI-driven system targets real-time, lab-quality disease detection at the point of care
Medtronic (NYSE: MDT)+
this week announced it received CE Mark approval for an expanded indication of its Evolut Pro+ and Evolut FX TAVI systems, allowing the devices to be used in “redo TAVI” procedures for patients with failing transcatheter aortic valves, regardless of the original manufacturer.
Natus Medical yesterday announced that it launched BrainWatch, a point-of-care EEG solution driven by AI.
Johnson & Johnson MedTech (NYSE: JNJ)+
announced today that it launched the SoundStar Crystal ultrasound catheter.
Route 92 Medical announced today that it received FDA 510(k) clearance for its HiPoint reperfusion system.
The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.
Pathways involved in DNA repair and other cellular functions could contribute to the development of Alzheimer’s.
New basivertebral nerve ablation device aims to relieve chronic vertebrogenic low back pain